Preferred Label : tepezza;
Origin ID : M000750865;
Related record
https://ansm.sante.fr/tableau-acces-derogatoire/tepezza
2026
false
false
false
France
French
insurance, health, reimbursement
tepezza
teprotumumab
teprotumumab
graves ophthalmopathy
graves disease
myxedema
infusions, intravenous
technical report
drug information
---
https://ansm.sante.fr/tableau-marr/teprotumumab
2026
false
false
false
France
French
risk management
teprotumumab
teprotumumab
antibodies, monoclonal, humanized
tepezza
Product containing only teprotumumab in parenteral dose form (medicinal product form)
drug information
patient education handout
infusions, intravenous
Embryo-foetal toxicity
hearing loss
---
https://www.has-sante.fr/jcms/p_3592956/fr/tepezza-teprotumumab-ophtalmopathie-basedowienne
2025
false
false
false
France
evaluation of the transparency committee
graves ophthalmopathy
tepezza
teprotumumab
---
